{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:46:42Z","timestamp":1784238402075,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xops.2026.101148","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:30:42Z","timestamp":1773131442000},"page":"101148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA\/LUCERNE"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-6998","authenticated-orcid":false,"given":"Jennifer I.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Ambresin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0426-7602","authenticated-orcid":false,"given":"Voraporn","family":"Chaikitmongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Eter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0807-8817","authenticated-orcid":false,"given":"Fumi","family":"Gomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad M.","family":"Khanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas J.S.","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Harrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5215-3373","authenticated-orcid":false,"given":"Philippe","family":"Margaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriji","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0276-1778","authenticated-orcid":false,"given":"Audrey","family":"Souverain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-6428","authenticated-orcid":false,"given":"Timothy Y.Y.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2026.101148_bib1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40123-020-00291-5","article-title":"Retinal pigment epithelial detachment in age-related macular degeneration","volume":"9","author":"Karampelas","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.xops.2026.101148_bib2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ajo.2007.06.014","article-title":"Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration","volume":"144","author":"Coscas","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ophtha.2014.11.017","article-title":"Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration","volume":"122","author":"Schmidt-Erfurth","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101148_bib4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ophtha.2013.12.029","article-title":"Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration","volume":"121","author":"Simader","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101148_bib5","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.ophtha.2016.03.037","article-title":"Morphology and visual acuity in aflibercept and ranibizumab therapy for neovascular age-related macular degeneration in the VIEW trials","volume":"123","author":"Waldstein","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101148_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ophtha.2015.09.013","article-title":"Predictive value of retinal morphology for visual acuity outcomes of different ranibizumab treatment regimens for neovascular AMD","volume":"123","author":"Waldstein","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101148_bib7","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/IAE.0000000000003098","article-title":"The incidence, characteristics, management, prognosis, and classification of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy","volume":"41","author":"Zhao","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101148_bib8","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/eye.2010.134","article-title":"Angiographic and OCT features of retinal angiomatous proliferation","volume":"24","author":"Rouvas","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101148_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.survophthal.2020.05.003","article-title":"Influence of pigment epithelial detachment on visual acuity in neovascular age-related macular degeneration","volume":"66","author":"Cheong","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12886-023-02797-5","article-title":"Predictive value of pigment epithelial detachment markers for visual acuity outcomes in neovascular age-related macular degeneration","volume":"23","author":"Shu","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2020.12.012","article-title":"Automated quantitative assessment of retinal fluid volumes as important biomarkers in neovascular age-related macular degeneration","volume":"224","author":"Keenan","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9994098","article-title":"OCT biomarkers in neovascular age-related macular degeneration: a narrative review","volume":"2021","author":"Metrangolo","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000516108","article-title":"Imaging biomarkers and their impact on therapeutic decision-making in the management of neovascular age-related macular degeneration","volume":"244","author":"Wong","year":"2021","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.xops.2026.101148_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/IAE.0000000000003935","article-title":"Pigment epithelial detachment thickness and variability affects visual outcomes in patients with neovascular age-related macular degeneration","volume":"44","author":"Sarraf","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101148_bib15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00417-023-06335-3","article-title":"Longitudinal changes in pigment epithelial detachment composition indices (PEDCI): new biomarkers in neovascular age-related macular degeneration","volume":"262","author":"Selvam","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41598-018-36704-6","article-title":"Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study","volume":"9","author":"Lai","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2026.101148_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00417-002-0505-8","article-title":"Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications","volume":"240","author":"Pauleikhoff","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/APO.0000000000000551","article-title":"Optical coherence tomography features for identifying posttreatment complete polypoidal regression in polypoidal choroidal vasculopathy","volume":"11","author":"Chaikitmongkol","year":"2022","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.xops.2026.101148_bib19","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00417-019-04456-2","article-title":"Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept","volume":"257","author":"Hara","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.15252\/emmm.201505889","article-title":"Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases","volume":"8","author":"Regula","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.xops.2026.101148_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2026.101148_bib22","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","article-title":"Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data","volume":"35","author":"Joussen","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101148_bib23","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2147\/OPTH.S231913","article-title":"Neovascular age-related macular degeneration (nAMD): a review of emerging treatment options","volume":"16","author":"Tan","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100076","article-title":"TENAYA and LUCERNE: rationale and design for the phase 3 clinical trials of faricimab for neovascular age-related macular degeneration","volume":"1","author":"Khanani","year":"2021","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2026.101148_bib25","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ophtha.2024.02.014","article-title":"TENAYA and LUCERNE: 2-year results from the phase 3 nAMD trials of faricimab with treat-and-extend dosing in year 2","volume":"131","author":"Khanani","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101148_bib26","first-page":"2185","article-title":"Faricimab rapidly improves fluid parameters in patients with nAMD","volume":"64","author":"Querques","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101148_bib27","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/s41433-020-0803-6","article-title":"The relationship between pigment epithelial detachment and visual outcome in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"34","author":"Cheong","year":"2020","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101148_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ajo.2016.09.004","article-title":"A perspective on the nature and frequency of pigment epithelial detachments","volume":"172","author":"Tan","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib29","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s00417-024-06421-0","article-title":"Short-term outcomes of treatment switch to faricimab in patients with aflibercept-resistant neovascular age-related macular degeneration","volume":"262","author":"Schneider","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib30","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1038\/s41433-023-02553-5","article-title":"The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results","volume":"37","author":"Khanani","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101148_bib31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.oret.2023.10.018","article-title":"Clinical outcomes of faricimab in patients with previously treated neovascular age-related macular degeneration","volume":"8","author":"Pandit","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101148_bib32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.oret.2023.08.018","article-title":"Short-term outcomes of faricimab in patients with neovascular age-related macular degeneration on prior anti-VEGF therapy","volume":"8","author":"Szigiato","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101148_bib33","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s40123-024-01005-x","article-title":"Faricimab in neovascular AMD complicated by pigment epithelium detachment: an AI-assisted evaluation of early morphological changes","volume":"13","author":"Veritti","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"Pt 5","key":"10.1016\/j.xops.2026.101148_bib34","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/eye.1988.106","article-title":"Evolution of geographic atrophy of the retinal pigment epithelium","volume":"2","author":"Sarks","year":"1988","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101148_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajo.2018.03.038","article-title":"Long-term choroidal thickness changes in eyes with drusenoid pigment epithelium detachment","volume":"191","author":"Dolz-Marco","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12886-023-02993-3","article-title":"Geographic atrophy after reabsorption of pigment epithelial detachment (GARPED) study","volume":"23","author":"Peng","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ophtha.2020.06.028","article-title":"HAWK and HARRIER: Ninety-six-week outcomes from the phase 3 trials of brolucizumab for neovascular age-related macular degeneration","volume":"128","author":"Dugel","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101148_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.oret.2024.07.012","article-title":"Effect of brolucizumab and aflibercept on the maximum thickness of pigment epithelial detachments and sub-retinal pigment epithelium fluid in HAWK and HARRIER","volume":"9","author":"Khanani","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2026.101148_bib39","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.ophtha.2016.07.007","article-title":"Ranibizumab treatment for pigment epithelial detachment secondary to neovascular age-related macular degeneration: post hoc analysis of the HARBOR study","volume":"123","author":"Sarraf","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101148_bib40","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.3390\/jcm12175496","article-title":"Clinical characteristics of eyes with neovascular age-related macular degeneration and retinal pigment epithelium tears","volume":"12","author":"Nagata","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.xops.2026.101148_bib41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/IAE.0b013e3180cc2612","article-title":"Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration","volume":"27","author":"Chan","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101148_bib42","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/IAE.0000000000001009","article-title":"Retinal pigment epithelial tear after intravitreal ranibizumab treatment for neovascular age-related macular degeneration","volume":"36","author":"Cho","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101148_bib43","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.ophtha.2011.05.026","article-title":"Incidence of retinal pigment epithelial tears after intravitreal ranibizumab injection for neovascular age-related macular degeneration","volume":"118","author":"Cunningham","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101148_bib44","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/IAE.0000000000000056","article-title":"Pigment epithelial tears associated with anti-VEGF therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in age-related macular degeneration","volume":"34","author":"Doguizi","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101148_bib45","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/sj.eye.6703098","article-title":"Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration","volume":"23","author":"Gelisken","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101148_bib46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1755-3768.2009.01547.x","article-title":"Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration","volume":"88","author":"Konstantinidis","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.xops.2026.101148_bib47","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/eye.2008.145","article-title":"Can the risk of retinal pigment epithelium tears after bevacizumab treatment be predicted? An optical coherence tomography study","volume":"22","author":"Leitritz","year":"2008","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2026.101148_bib48","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.3390\/jcm12155145","article-title":"Short-term outcomes of faricimab treatment in aflibercept-refractory eyes with neovascular age-related macular degeneration","volume":"12","author":"Kishi","year":"2023","journal-title":"J Clin Med"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526000862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526000862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:40:30Z","timestamp":1778924430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526000862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666914526000862"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101148","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction in Pigment Epithelial Detachment Thickness with Faricimab versus Aflibercept 2 mg during Head-to-Head Dosing in TENAYA\/LUCERNE","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101148"}}